Editorial overview: Steroid therapy for exudative age-related macular degeneration: Bridging the gap until a cure is found

Current Opinion in Investigational Drugs

Volumn 7, Issue 1, 2006, Pages 18-19

  Mozaffarieh, Maneli ^a   Wedrich, Andreas ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PLACEBO; STEROID; TRIAMCINOLONE ACETONIDE;

BLINDNESS; CATARACT; CLINICAL TRIAL; DIABETIC MACULAR EDEMA; DRUG DOSE REGIMEN; ENDOPHTHALMITIS; FOLLOW UP; HEALTH CARE COST; HUMAN; INFECTION; INTRAOCULAR HYPERTENSION; LONG TERM CARE; OPTIC NERVE DISEASE; PATIENT EDUCATION; QUALITY OF LIFE; RETINA DISEASE; RETINA EXUDATE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; REVIEW; RISK BENEFIT ANALYSIS; UNITED KINGDOM; AGING; EDITORIAL; RETINA MACULA DEGENERATION;

AGING; HUMANS; MACULAR DEGENERATION; QUALITY OF LIFE; STEROIDS;

EID: 30944449200     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Bressler NM, Bressler SB, Fine SL: Age-related macular degeneration. Surv Ophthalmol (1988) 32(6):375-413.
2. Klein R, Klein BE, Linton KL: Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1992) 99(6):933-943.
3. Mozaffarieh M, Sacu S, Wedrich A: The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: A review based on controversial evidence. Nutr J (2003) 2:20.
4. Ciulla TA, Criswell MH, Danis RP, Hill TE: Intravitreal triamcinolone acetonide inhibit choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol (2001) 119(3):399-404.
5. Danis RP, Bingaman DP, Yang Y, Ladd B: Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology (1996) 103(12):2099-2104.
6. Leibowitz HM, Bartlett JD, Rich R, McQuirter H, Stewart R, Assil K: Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids. Arch Ophthalmol (1996) 114(8):933-937.
7. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA: Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol (1998) 26(4):277-281.
8. Danis RP, Ciulla TA, Pratt LM, Anliker W: Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina (2000) 20(3):244-250.
9. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R: Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol (2003) 87(4):462-468.
10. Rodriguez-Coleman H, Yuan P, Kim H, Gravlin L, Srivastava S, Csaky KG, Robinson MR: Intravitreal injection of triamcinolone for diffuse macular edema. Arch Ophthalmol (2004) 122(7):1085-1086.
11. Penfold PL, Wen L, Madigan MC, Gillies MC, King NJ, Provis JM: Triamcinolone-acetonide modulates permeablility and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: Implications for macular degeneration. Clin Exp Immunol (2000) 121(3):458-465.
12. Penfold PL, Wong JG, Gyory J, Billson FA: Effects of triamcinolone acetonide on microglial morphology quantitative expression of MHC-II in exudative age-related macular degeneration. Clin Experiment Ophthalmol (2001) 29(3):188-192.
13. Jonas JB, Kreissig I, Sofker A, Degenring RF: Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol (2003) 121(1):57-61.
14. Mozaffarieh M, Krepler K, Heinzl H, Sacu S, Wedrich A: Visual function, quality of life and patient satisfaction after ophthalmic surgery: A comparative study. Ophthalmologica (2004) 218(1):26-30.
15. Pollack A, Bukelman A, Zalish M, Leiba H, Oliver M: The course of age-related macular degeneration following bilateral cataract surgery. Ophthalmic Surg Lasers (1998) 29(4):286-294.
16. Van de Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, Pameyer JH, de Jong PT: Increased prevalence of disciform macular degeneration after cataract extraction with implantation of an intraocular lens. Br J Ophthalmol (1994) 78(6):441-445.
17. Shuttleworth GN, Luhishi EA, Harrad RA: Do patients with age related maculopathy and cataract benefit from cataract surgery? Br J Ophthalmol (1998) 82(6):611-616.
18. Armbrecht AM, Findlay C, Kaushal S, Aspinall P, Hill AR, Dhillon B: Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. Br J Ophthalmol (2000) 84(12):1343-1348.
19. Engelman CJ, Palmer JD, Egbert P: Orbital abscess following subtenon triamcinolone injection. Arch Ophthalmol (2004) 122(4):654-655.
20. Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A: Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina (2003) 23(5):686-691.
21. Sutter FK, Gillies MC: Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol (2003) 87(8):972-974.